학술논문


EBSCO Discovery Service
발행년
-
(예 : 2010-2015)
전자자료 공정이용 안내

우리 대학 도서관에서 구독·제공하는 모든 전자자료(데이터베이스, 전자저널, 전자책 등)는 국내외 저작권법과 출판사와의 라이선스 계약에 따라 엄격하게 보호를 받고 있습니다.
전자자료의 비정상적 이용은 출판사로부터의 경고, 서비스 차단, 손해배상 청구 등 학교 전체에 심각한 불이익을 초래할 수 있으므로, 아래의 공정이용 지침을 반드시 준수해 주시기 바랍니다.

공정이용 지침
  • 전자자료는 개인의 학습·교육·연구 목적의 비영리적 사용에 한하여 이용할 수 있습니다.
  • 합리적인 수준의 다운로드 및 출력만 허용됩니다. (일반적으로 동일 PC에서 동일 출판사의 논문을 1일 30건 이하 다운로드할 것을 권장하며, 출판사별 기준에 따라 다를 수 있습니다.)
  • 출판사에서 제공한 논문의 URL을 수업 관련 웹사이트에 게재할 수 있으나, 출판사 원문 파일 자체를 복제·배포해서는 안 됩니다.
  • 본인의 ID/PW를 타인에게 제공하지 말고, 도용되지 않도록 철저히 관리해 주시기 바랍니다.
불공정 이용 사례
  • 전자적·기계적 수단(다운로딩 프로그램, 웹 크롤러, 로봇, 매크로, RPA 등)을 이용한 대량 다운로드
  • 동일 컴퓨터 또는 동일 IP에서 단시간 내 다수의 원문을 집중적으로 다운로드하거나, 전권(whole issue) 다운로드
  • 저장·출력한 자료를 타인에게 배포하거나 개인 블로그·웹하드 등에 업로드
  • 상업적·영리적 목적으로 자료를 전송·복제·활용
  • ID/PW를 타인에게 양도하거나 타인 계정을 도용하여 이용
  • EndNote, Mendeley 등 서지관리 프로그램의 Find Full Text 기능을 이용한 대량 다운로드
  • 출판사 콘텐츠를 생성형 AI 시스템에서 활용하는 행위(업로드, 개발, 학습, 프로그래밍, 개선 또는 강화 등)
위반 시 제재
  • 출판사에 의한 해당 IP 또는 기관 전체 접속 차단
  • 출판사 배상 요구 시 위반자 개인이 배상 책임 부담
'학술논문' 에서 검색결과 47건 | 목록 1~20
Academic Journal
Nikiphorou, E, Studenic, P, Gytz Ammitzboll, C, Canavan, M, Jani, M, Ospelt, C & Berenbaum, F 2017, 'Social Media Use Among Young Rheumatologists and Basic Scientists: results of an International Survey by the Emerging Eular Network (EMEUNET)', Annals of the rheumatic diseases, vol. 76, no. 4, pp. 712-715. https://doi.org/10.1136/annrheumdis-2016-209718
Nikiphorou, E, Studenic, P, Ammitzboll, C G, Canavan, M, Jani, M, Ospelt, C, Berenbaum, F & EMEUNET 2017, 'Social media use among young rheumatologists and basic scientists : results of an international survey by the Emerging EULAR Network (EMEUNET)', Annals of the Rheumatic Diseases, vol. 76, no. 4, pp. 712-715. https://doi.org/10.1136/annrheumdis-2016-209718
Academic Journal
Axelsen, M B, Eshed, I, Hørslev-Petersen, K, Stengaard-Pedersen, K, Hetland, M L, Møller, J, Junker, P, Pødenphant, J, Schlemmer, A, Ellingsen, T, Ahlquist, P, Lindegaard, H, Linauskas, A, Dam, M Y, Hansen, I, Horn, H C, Ammitzbøll, C G, Jørgensen, A, Krintel, S B, Raun, J, Krogh, N S, Johansen, J S, Ostergaard, M & OPERA study group 2015, 'A treat-to-target strategy with methotrexate and intra-articular triamcinolone with or without adalimumab effectively reduces MRI synovitis, osteitis and tenosynovitis and halts structural damage progression in early rheumatoid arthritis : Results from the OPERA randomised controlled trial', Annals of the Rheumatic Diseases, vol. 74, no. 5, pp. 867-875. https://doi.org/10.1136/annrheumdis-2013-204537
Axelsen, M B, Eshed, I, Hørslev-Petersen, K, Stengaard-Pedersen, K, Hetland, M L, Møller, J R, Junker, P, Pødenphant, J, Schlemmer, A, Ellingsen, T, Ahlquist, P, Lindegaard, H, Linauskas, A, Dam, M Y, Hansen, I T, Horn, H C, Ammitzbøll, C G, Jørgensen, A J, Krintel, S B, Raun, J, Krogh, N S, Johansen, J S, Ostergaard, M & OPERA Study Group 2015, ' A treat-to-target strategy with methotrexate and intra-articular triamcinolone with or without adalimumab effectively reduces MRI synovitis, osteitis and tenosynovitis and halts structural damage progression in early rheumatoid arthritis: results from the OPERA randomised controlled trial ', Annals of the Rheumatic Diseases, vol. 74, no. 5, pp. 867-875 . https://doi.org/10.1136/annrheumdis-2013-204537
Axelsen, M B, Eshed, I, Hørslev-Petersen, K, Stengaard-Pedersen, K, Hetland, M L, Møller, J, Junker, M P, Pødenphant, J, Schlemmer, A, Ellingsen, T, Ahlquist, P, Lindegaard, H, Linauskas, A, Dam, M Y, Hansen, I, Horn, H C, Ammitzbøll, C G, Jørgensen, A, Krintel, S B, Raun, J, Krogh, N S, Johansen, J S, Østergaard, M & OPERA Study Group 2014, 'A treat-to-target strategy with methotrexate and intra-articular triamcinolone with or without adalimumab effectively reduces MRI synovitis, osteitis and tenosynovitis and halts structural damage progression in early rheumatoid arthritis : results from the OPERA randomised controlled trial', Annals of the Rheumatic Diseases. https://doi.org/10.1136/annrheumdis-2013-204537
Academic Journal
Hørslev-Petersen, K, Hetland, M L, Junker, P, Pødenphant, J, Ellingsen, T, Ahlquist, P, Lindegaard, H, Linauskas, A, Schlemmer, A, Dam, M Y, Hansen, I, Horn, H C, Ammitzbøll, C G, Jørgensen, A, Krintel, S B, Raun, J, Johansen, J S, Ostergaard, M, Stengaard-Pedersen, K & OPERA study-group 2014, 'Adalimumab added to a treat-to-target strategy with methotrexate and intra-articular triamcinolone in early rheumatoid arthritis increased remission rates, function and quality of life. The OPERA Study : An investigator-initiated, randomised, double-blind, parallel-group, placebo-controlled trial', Annals of the Rheumatic Diseases, vol. 73, no. 4, pp. 654-661. https://doi.org/10.1136/annrheumdis-2012-202735
OPERA Study Group 2014, ' Adalimumab added to a treat-to-target strategy with methotrexate and intra-articular triamcinolone in early rheumatoid arthritis increased remission rates, function and quality of life : The OPERA Study: an investigator-initiated, randomised, double-blind, parallel-group, placebo-controlled trial ', Annals of the Rheumatic Diseases, vol. 73, no. 4, pp. 654-661 . https://doi.org/10.1136/annrheumdis-2012-202735
Hørslev-Petersen, K, Hetland, M L, Junker, P, Pødenphant, J, Ellingsen, T, Ahlquist, P, Lindegaard, H, Linauskas, A, Schlemmer, A, Dam, M Y, Tønder Hansen, I, Horn, H C, Ammitzbøll, C G, Jørgensen, A, Krintel, S B, Raun, J, Johansen, J S, Østergaard, M, Stengaard-Pedersen, K & OPERA Study Group 2013, 'Adalimumab added to a treat-to-target strategy with methotrexate and intra-articular triamcinolone in early rheumatoid arthritis increased remission rates, function and quality of life. The OPERA Study : an investigator-initiated, randomised, double-blind, parallel-group, placebo-controlled trial', Annals of the Rheumatic Diseases. https://doi.org/10.1136/annrheumdis-2012-202735
Conference
Brahe, C H, Østergaard, M, Johansen, J S, Defranoux, N A, Wang, X, Bolce, R J, Sasso, E H, Hørslev-Petersen, K, Stengaard-Pedersen, K, Ornbjerg, L M, Junker, P, Ellingsen, T J, Ahlquist, P, Lindegaard, H M, Linauskas, A, Schlemmer, A, Dam, M Y, Hansen, I T, Lottenburger, T, Ammitzbøll, C G, Jørgensen, A, Krintel, S B, Lillelund Raun, J & Hetland, M L 2016, ' Multi-Biomarker Disease Activity (MBDA) Score and Prediction of Radiographic Progression in a Randomized Study of Patients with Early RA Treated with Methotrexate Alone or with Adalimumab ', ACR/ARHP Annual Meeting, Washington, United States, 11/11/2016-16/11/2016 .
Conference
Ornbjerg, L M, Østergaard, M, Jensen, T D, Hørslev-Petersen, K, Stengaard-Pedersen, K, Junker, P, Ellingsen, T J, Ahlquist, P, Lindegaard, H M, Linauskas, A, Schlemmer, A, Dam, M Y, Hansen, I T, Lottenburger, T, Ammitzbøll, C G, Jørgensen, A, Krintel, S B, Lillelund Raun, J & Hetland, M L 2016, ' Hand Bone Loss in Early Rheumatoid Arthritis Is Independent of Adalimumab Treatment-Results from a Randomized Controlled Clinical Trial. ', ACR/ARHP Annual Meeting, Washington, United States, 11/11/2016-16/11/2016 .
Conference
Ørnbjerg, LM, Østergaard, M, Jensen, T, Hørslev-Petersen, K, Stengaard-Pedersen, K, Junker, P, Ellingsen, T J, Ahlquist, P, Lindegaard, H M, Linauskas, A, Schlemmer, A, Dam, M Y, Hansen, I, Lottenburger, T, Ammitzbøll, C G, Jørgensen, A, Krintel, S B, Lillelund Raun, J & Hetland, M 2016, ' HAND BONE LOSS IN EARLY RHEUMATOID ARTHRITIS IS INDEPENDENT OF ADALIMUMAB TREATMENT. A SUBSTUDY OF THE OPTIMIZED TREATMENT ALGORITHM IN EARLY RA (OPERA) TRIAL ', 17th Annual European Congress of Rheumatology, London, United Kingdom, 08/06/2016-11/06/2016 . https://doi.org/10.1136/annrheumdis-2016-eular.3000
Ørnbjerg, L M, Østergaard, M, Jensen, T, Hørslev-Petersen, K, Stengaard-Pedersen, K, Junker, P, Ellingsen, T J, Ahlquist, P, Lindegaard, H M, Linauskas, A, Schlemmer, A, Dam, M Y, Hansen, I, Lottenburger, T, Ammitzbøll, C G, Jørgensen, A, Krintel, SB, Lillelund Raun, J & Hetland, M 2016, ' HAND BONE LOSS IN EARLY RHEUMATOID ARTHRITIS IS INDEPENDENT OF ADALIMUMAB TREATMENT. A SUBSTUDY OF THE OPTIMIZED TREATMENT ALGORITHM IN EARLY RA (OPERA) TRIAL ', 17th Annual European Congress of Rheumatology, London, United Kingdom, 08/06/2016-11/06/2016 .
Conference
Axelsen, M B, Eshed, I, Hørslev-Petersen, K, Steengaard-Petersen, K, Hetland, M L, Møller, J M, Junker, P, Pødenphant, J, Ellingsen, T, Ahlquist, P, Lindegaard, H M, Linauskas, A, Schlemmer, A, Dam, M Y, Hansen, I, Horn, H C, Ammitzbøll, C G, Jørgensen, A, Krintel, S B, Raun, J, Johansen, J S, Krogh, N S & Østergaard, M 2013, 'A Treat-To-Target Strategy With Methotrexate and Intra-Articular Triamcinolone With Or Without Added Adalimumab Reduces Synovitis, Osteitis and Tenosynovitis and Halts Structural Damage Progression In Early Rheumatoid Arthritis : The Opera Magnetic Resonance Imaging Sub-Study', Arthritis & Rheumatism, vol. 65, no. S10, 2802, pp. S1199. < http://onlinelibrary.wiley.com/doi/10.1002/art.v65.S10/issuetoc >
Axelsen, M B, Eshed, I, Hørslev-Petersen, K, Steengaard-Petersen, K, Hetland, M L, Møller, J M, Junker, P, Pødenphant, J, Ellingsen, T, Ahlquist, P, Lindegaard, H M, Linauskas, A, Schlemmer, A, Dam, M Y, Hansen, I, Horn, H C, Ammitzbøll, C G, Jørgensen, A, Krintel, S B, Raun, J, Johansen, J S, Krogh, N S & Østergaard, M 2013, ' A Treat-To-Target Strategy With Methotrexate and Intra-Articular Triamcinolone With Or Without Added Adalimumab Reduces Synovitis, Osteitis and Tenosynovitis and Halts Structural Damage Progression In Early Rheumatoid Arthritis : The Opera Magnetic Resonance Imaging Sub-Study ', Arthritis & Rheumatism, vol. 65, no. S10, 2802, pp. S1199 . < http://onlinelibrary.wiley.com/doi/10.1002/art.v65.S10/issuetoc >
Bjørndal Axelsen, M, Eshed, I, Hørslev-Petersen, K, Stengaard-Pedersen, K, Hetland, M L, M. Møller, J, Junker, P, Pødenphant, J, Ellingsen, T, Ahlqvist, P, Lindegaard, H M, Linauskas, A, Schlemmer, A, Yde Dam, M, Hansen, I, Horn, H C, Ammitzbøll, C G, Jørgensen, A, Krintel, S B, Raun, J, Johansen, J S, Steen Krogh, N & Østergaard, M 2013, ' A Treat-To-Target Strategy With Methotrexate And Intra-Articular Triamcinolone With Or Without Added Adalimumab Reduces Synovitis, Osteitis And Tenosynovitis And Halts Structural Damage Progression In Early Rheumatoid Arthritis : The OPERA Magnetic Resonance Imaging Sub-Study ', ACR Annual Meeting 2013, San Diego, United States, 25/10/2013-30/10/2013 .
Conference
Krintel, S B, Dehlendorff, C, Hetland, M L, Hørslev-Petersen, K, Andersen, K, Junker, P, Pødenphant, J, Ellingsen, T, Ahlqvist, P, Lindegaard, H M, Linauskas, A, Schlemmer, A, Y. Dam, M, Hansen, I, Horn, H C, Jørgensen, A, Raun, J, Ammitzbøll, C G, Stengaard-Pedersen, K & Johansen, J S 2013, ' MicroRNA Expression Profiles Associated With Response To Adalimumab and Methotrexate: A Placebo-Controlled Clinical Trial ', ACR Annual Meeting 2013, San Diego, United States, 25/10/2013-30/10/2013 .
Conference
Ammitzbøll, C G, Steffensen, R, Bøgsted, M, Nielsen, K R, Ellingsen, T, Hetland, M L, Junker, P, Pødenphant, J, Østergaard, M, Johansen, J, Hørslev-Petersen, K & Stengaard-Pedersen, K 2015, 'Associations Between 49 Susceptibility SNPs and Disease Activity Including Radiographic Damage in Early Untreated Rheumatoid Arthritis', Arthritis & rheumatology (Hoboken, N.J.), vol. 67, no. suppl 10, 2589. https://doi.org/10.1002/art.39448
Ammitzbøll, C G, Steffensen, R N, Bøgsted, M, Nielsen, K R, Ellingsen, T, Hetland, M L, Junker, P, Pødenphant, J, Østergaard, M, Johansen, J, Hørslev-Petersen, K & Stengaard-Pedersen, K 2015, ' Associations Between 49 Susceptibility SNPs and Disease Activity Including Radiographic Damage in Early Untreated Rheumatoid Arthritis ', ACR/ARHP, San Francisco, United States, 07/11/2015-11/11/2015 .
Ammitzbøll, C G, Steffensen, R, Bøgsted, M, Nielsen, K R, Ellingsen, T, Hetland, M L, Junker, P, Pødenphandt, J, Østergaard, M, Johansen, J, Hørslev-Petersen, K & Stengaard-Pedersen, K 2015, ' Associations Between 49 Susceptibility SNPs and Disease Activity Including Radiographic Damage in Early Untreated Rheumatoid Arthritis ', ACR/ARHP, San Francisco, United States, 07/11/2015-11/11/2015 .
Conference
Ammitzbøll, C G, Steffensen, R, Bøgsted, M, Hørslev-Petersen, K, Hetland, M L, Junker, P, Pødenphant, J, Østergaard, M, Ellingsen, T, Johansen, J & Steengaard-Pedersen, K 2014, 'Genotype and haplotype effects of 7 single-nucleotide polymorphisms in the CRP gene on levels of C-reactive protein and DAS28 in two cohorts of treatment naïve, recent onset rheumatoid arthritis patients', European League Against Rheumatism, Paris, France, 11/06/2014-14/06/2014. < http://www.abstracts2view.com/eular/ >
Ammitzbøll, C G, Steffensen, R, Bøgsted, M, Hørslev-Petersen, K, Hetland, M L, Junker, P, Pødenphant, J, Østergaard, M, Ellingsen, T, Johansen, J S & Stengaard-Pedersen, K 2014, ' Genotype and haplotype effects of 7 single-nucleotide polymorphisk in the CRP gene on levels of C-reactive protein and DAS28 in two cohorts of treatment naïve, recent onset rheumatoid arthritis patients ', The 15th Annual European Congress of Rheumatology EULAR 2014, Paris, France, 11/06/2014-14/06/2014 .
Conference
Hørslev-Petersen, K, Ørnbjerg, L M, Hetland, M L, Junker, P, Pødenphant, J, Ellingsen, T, Ahlquist, P, Lindegaard, H M, Linauskas, A, Schlemmer, A, Dam, M Y, Hansen, I, Lottenburger, T, Jørgensen, A, Krintel, S B, Raun, J, Ammitzbøll, C G, Johansen, J, Østergaard, M & Stengaard-Pedersen, K 2013, 'Induction Therapy With Adalimumab On Top Of An Aggressive Treat-To-Target Strategy With Methotrexate and Intraarticular Corticosteroid Reduces Radiographic Erosive Progression In Early Rheumatoid Arthritis, Even After Withdrawal Of Adalimumab. Results Of a 2-Year Trial (OPERA)', Arthritis & Rheumatism, vol. 65, no. S10, 1420, pp. S600-S601. < http://onlinelibrary.wiley.com/doi/10.1002/art.v65.S10/issuetoc >
Hørslev-Petersen, K, Ørnbjerg, L M, Hetland, M L, Junker, P, Pødenphant, J, Ellingsen, T, Ahlquist, P, Lindegaard, H M, Linauskas, A, Schlemmer, A, Dam, M Y, Hansen, I, Lottenburger, T, Jørgensen, A, Krintel, S B, Raun, J, Ammitzbøll, C G, Johansen, J, Østergaard, M & Stengaard-Pedersen, K 2013, ' Induction Therapy With Adalimumab On Top Of An Aggressive Treat-To-Target Strategy With Methotrexate and Intraarticular Corticosteroid Reduces Radiographic Erosive Progression In Early Rheumatoid Arthritis, Even After Withdrawal Of Adalimumab. Results Of a 2-Year Trial (OPERA) ', Arthritis & Rheumatism, vol. 65, no. S10, 1420, pp. S600-S601 . < http://onlinelibrary.wiley.com/doi/10.1002/art.v65.S10/issuetoc >
Hørslev-Petersen, K, Ørnbjerg, L M, Hetland, M L, Junker, P, Pødenphant, J, Ellingsen, T, Ahlqvist, P, Lindegaard, H M, Linauskas, A, Schlemmer, A, Y. Dam, M, Hansen, I, Lottenburger, T, Jørgensen, A, Krintel, S B, Raun, J, Ammitzbøll, C G, Johansen, J, Østergaard, M & Stengaard-Pedersen, K 2013, ' Induction Therapy With Adalimumab On Top Of An Aggressive Treat-To-Target Strategy With Methotrexate and Intraarticular Corticosteroid Reduces Radiographic Erosive Progression In Early Rheumatoid Arthritis, Even After Withdrawal Of Adalimumab : Results Of a 2-Year Trial (OPERA) ', ACR Annual Meeting 2013, San Diego, United States, 25/10/2013-30/10/2013 .
Conference
Hørslev-Petersen, K, Hetland, M L, Junker, P, Pødenphant, J, Ellingsen, T, Ahlqvist, P, Lindegaard, H M, Linauskas, A, Schlemmer, A, Y. Dam, M, Hansen, I, Lottenburger, T, Jørgensen, A, Krintel, S B, Raun, J, Ammitzbøll, C G, Johansen, J, Østergaard, M & Stengaard-Pedersen, K 2013, ' Independent Of Induction Therapy With Adalimumab; Year 2 Clinical Results Of An Investigator-Initiated Randomised, Controlled Clinical Trial Of Early, Rheumatoid Arthritis (OPERA) ', ACR Annual Meeting 2013, San Diego, United States, 25/10/2013-30/10/2013 .
Conference
Hørslev-Petersen, K, Hetland, M L, Junker, P, Pødenphant, J, Ellingsen, T J, Ahlqvist, P, Lindegaard, H M, Linauskas, A, Schlemmer, A, Dam, M Y, Hansen, I T, Lottenburger, T, Jørgensen, A, Krintel, S B, Raun, J L, Ammitzbøll, C G, Johansen, J S, Østergaard, M & Stengaard-Pedersen, K 2013, ' Improved remission rates acquired by adding Adalimumab to Methotrexate and intraarticular glucocorticoid cannot be maintained after withdrawal of Adalimumab. A 2-year investigator initiated randomised, controlled study on early rheumatoid arthritis ', EULAR 2013 Madrid, Madrid, Spain, 12/06/2013-15/06/2013 .
Hørslev-Petersen, K, Hetland, ML, Junker, P, Pødenphant, J, Ellingsen, T J, Ahlqvist, P, Lindegaard, H M, Linauskas, A, Schlemmer, A, Dam, MY, Hansen, I, Lottenburger, T, Jørgensen, A, Krintel, SB, Raun, J, Ammitzbøll, C G, Johansen, JS, Østergaard, M & Stengaard-Pedersen, K 2013, ' Improved remission rates acquired by adding adalimumab to methotrexate and intraarticular glucocorticoid cannot be maintained after withdrawal of adalimumab : A 2-year investigator initiated randomised, controlled study on early rheumatod arthritis ', EULAR 2013 Madrid, Madrid, Spain, 12/06/2013-15/06/2013 .
Academic Journal
Arthritis Res Ther
Ammitzbøll, C, Steffensen, R, Bøgsted, M, Hørslev-Petersen, K, Hetland, M L, Junker, P, Johansen, J S, Pødenphant, J, Ostergaard, M, Ellingsen, T & Stengaard-Pedersen, K 2014, 'CRP genotype and haplotype associations with serum C-reactive protein level and DAS28 in untreated early rheumatoid arthritis patients', Arthritis Research & Therapy, vol. 16, no. 5, 475. https://doi.org/10.1186/s13075-014-0475-3
Ammitzbøll, C G, Steffensen, R, Bøgsted, M, Hørslev-Petersen, K, Hetland, M L, Junker, P, Johansen, J S, Pødenphant, J, Østergaard, M, Ellingsen, T & Stengaard-Pedersen, K 2014, ' CRP genotype and haplotype associations with serum C-reactive protein level and DAS28 in untreated early rheumatoid arthritis patients ', Arthritis Research & Therapy
, vol. 16, no. 5, 475, pp. 1-8 . https://doi.org/10.1186/s13075-014-0475-3
Ammitzbøll, C, Steffensen, R, Bøgsted, M, Hørslev-Petersen, K, Hetland, M L, Junker, P, Johansen, J S, Pødenphant, J, Ostergaard, M, Ellingsen, T & Stengaard-Pedersen, K 2014, ' CRP genotype and haplotype associations with serum C-reactive protein level and DAS28 in untreated early rheumatoid arthritis patients ', Arthritis Research & Therapy, vol. 16, no. 1, 475 . https://doi.org/10.1186/s13075-014-0475-3
Ammitzbøll, C G, Steffensen, R, Bøgsted, M, Hørslev-Petersen, K, Hetland, M L, Junker, P, Johansen, J S, Pødenphant, J, Østergaard, M, Ellingsen, T & Stengaard-Pedersen, K 2014, 'CRP genotype and haplotype associations with serum C-reactive protein level and DAS28 in untreated early rheumatoid arthritis patients', Arthritis research & therapy, vol. 16, no. 5, pp. 475. https://doi.org/10.1186/s13075-014-0475-3
Conference
Hørslev-Petersen, K, Hetland, M L, Junker, P, Pødenphant, J, Ellingsen, T J, Ahlquist, P, Lindegaard, H M, Linauskas, A, Schlemmer, A, Dam, M Y, Hansen, I T, Horn, H C, Jørgensen, A, Krintel, S B, Raun, J L, Ammitzbøll, C G, Johansen, J S, Østergaard, M & Stengaard-Pedersen, K 2012, ' REMISSION RATES INCREASE SUBSTANTIALLY BY ADDING ADALIMUMAB TO METHOTREXATE AND INTRA-ARTICULAR GLUCOCORTICOID IN PATIENTS WITH EARLY RHEUMATOID ARTHRITIS-1-YEAR RESULTS OF INVESTIGATOR-INITIATED DOUBLE BLINDED RANDOMIZED CLINICAL TRIAL (OPER <) ', Annals of the Rheumatic Diseases, vol. 71, no. suppl 3, pp. 360 .
Hørslev-Petersen, K, Hetland, M L, Junker, P, Pødenphant, J, Ellingsen, T J, Ahlquist, P, Lindegaard, H M, Linauskas, A, Schlemmer, A, Dam, M Y, Hansen, I T, Horn, H C, Jørgensen, A, Krintel, S B, Raun, J L, Ammitzbøll, C G, Johansen, J S, Østergaard, M & Stengaard-Pedersen, K 2012, ' Remission rates increase substantially by adding adalimumab to methotrexate and intra-articular glucocorticoid in patients with early rheumatoid arthritis : 1-year results of investigator-initiated, double-blinded randomized clinical trial ', Scandinavian Congress of Rheumatology, København, Denmark, 01/09/2012-05/09/2012 .
Hørslev-Petersen, K, Hetland, M L, Junker, P, Pødenphant, J, Ellingsen, T J, Ahlquist, P, Lindegaard, H M, Linauskas, A, Schlemmer, A, Dam, M Y, Hansen, I T, Horn, H C, Jørgensen, A, Krintel, S B, Raun, J L, Ammitzbøll, C G, Johansen, J S, Østergaard, M & Stengaard-Pedersen, K 2012, ' REMISSION RATES INCREASE SUBSTANTIALLY BY ADDING ADALIMUMAB TO METHOTREXATE AND INTRA-ARTICULAR GLUCOCORTICOID IN PATIENTS WITH EARLY RHEUMATOID ARTHRITIS-1-YEAR RESULTS OF INVESTIGATOR INITIATED, DOUBLE-BLINDED RANDOMIZED CLINICAL TRIAL ', EULAR 2012, Berlin, Germany, 06/06/2012-09/06/2012 .
Conference
Ammitzbøll, C G, Jensenius, J C, Ellingsen, T J, Thiel, S, Hørslev-Petersen, K, Hetland, M L, Junker, P, Johansen, J, Østergaard, M, Pødenphant, J & Stengaard-Pedersen, K 2012, ' M-Ficolin, an activator of the complement system is the strongest predictor of both DAS28 remission and low disease activity in a cohort of 180 early DMARD naïve rheumatoid arthritis patients followed in The OPERA-study. ', Arthritis & Rheumatism, vol. 64, no. 10, pp. S1065 .
검색 결과 제한하기
제한된 항목
[검색어] Ammitzboll, Christian Gytz
발행연도 제한
-
학술DB(Database Provider)
저널명(출판물, Title)
출판사(Publisher)
자료유형(Source Type)
주제어
언어